Updated
- Log In
- Newsletters
-
Subscribe
Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Biotechnology
3 Biotech Stocks Ready to Burn Up
Biotechs are known for wild tears. Investors, you'll want to consider these drug makers.
3 Biotech Stock Favorites to Bet on Today: Top Analysts
Follow the experts. These biotech stocks have Wall Street's best analysts getting bullish.
This Company Is at the Center of Insider Trading Charges Against Rep. Collins
Innate Immunotherapeutics of Australia is the biopharmaceutical company at the center of the insider trading charges leveled against New York Rep. Chris Collins.
Why Investors Should Favor Smaller Biotech Companies
Small and mid-cap biotech firms are driving innovation in the sector. Experts explain why investors should take notice.
Merck Beats Estimates and Raises Guidance, But Stock Plops 2%
Shares fell on Friday morning despite positive results for the second quarter.
Biogen Plummets as Alzheimer Drug Shows Little Efficacy in Trial
Shares have fallen more than 11% Thursday despite BAN2401 results showing improvement in reducing the rate of cognitive decline.
Biogen Shares Plummet Despite Alzheimer's Drug Exceeding Expectations
Shares fell by more than 11% in after hours trading Wednesday.
Buy These 3 Risky Biotech Stocks
Is the pharma sector fever heating up in 2H18? Drug investors, get ready as there could be some good trades to be made.
3 'Strong Buy' Healthcare Stocks Poised to Surge
Here are the top healthcare bets ticking all the boxes for analysts.
Biogen's Big Alzheimer's Presentation on Wednesday: What You Need to Know
The biotech giant will present detailed results of its mid-stage trials of BAN2401 at the Alzheimer's Association International Conference in Chicago.